A retrospective study in advanced NSCLC patients treated with 1L I-O therapy in the United States
Latest Information Update: 07 Jul 2021
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab (Primary) ; Carboplatin (Primary) ; Cisplatin (Primary) ; Paclitaxel (Primary) ; Pembrolizumab (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 07 Jul 2021 New trial record
- 01 Jun 2021 Results published in the Lung Cancer